乳房生検の世界市場:インサイト、市場機会、市場シェア、市場予測

◆英語タイトル:Global Breast Biopsy Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
◆商品コード:OCCAM60712
◆発行会社(調査会社):Occams Research
◆発行日:2016年6月
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥432,900見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥765,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、世界の乳房生検市場について調査・分析し、市場インサイト、市場機会、市場シェア、市場規模予測などを含め、以下の構成でお届けいたします。
・乳房生検の世界市場:イントロダクション
・乳房生検の世界市場:市場概観
・乳房生検の世界市場:市場動向(促進要因、阻害要因、市場機会)
・乳房生検の世界市場:セグメント別市場分析
・乳房生検の世界市場:主要地域別市場分析
・乳房生検の世界市場:関連企業分析
【レポートの概要】

The global breast biopsy market is estimated to grow at a CAGR of 12.1% and will contribute $769 million by 2022. Rising breast cancer incidences in women’s are one of the major factors that drive the global breast biopsy market. There are many other reasons such as rising women population, growing awareness regarding breast cancer and so on. Breast biopsy tests are generally used for diagnosing breast cancer and also as a checkup for other ailments in the breast, such as lump etc. and also breast cancer if identified during physical examination. There are many drivers of the global breast biopsy market. Increasing prevalence of female breast cancer is one of the major factors. The region with higher number of women’s are likely to act as a growth region for this market, Asia Pacific is the growing market in breast biopsy. Breast cancer is one of the common cancers in women worldwide. More than 3 million cases worldwide are being diagnosed for cancer. This data is expected to grow in near future. Rising incidence of cancer is one of the major reasons for the growth of global breast biopsy market. Increasing technology enables to lower the pain in the biopsy procedure and hence enhances the global market. Technology is the key factor that produces highly accurate and précised machineries, which extract the cancerous area with minimal invasion and less pain. This acts as an opportunity for the growth of the global breast biopsy market.

There are chances of infectious risks related to breast biopsy, which lower the demand and acts as a restraint in the growth of global breast biopsy market. High cost of breast biopsy is the major factor that hinders the growth of global breast biopsy market. Breast biopsy requires highly qualified doctors, surgeons and other medical teams and also demands high technological advanced machineries; which all adds up to the high cost of biopsy surgery as a result of which it is not in reach of common people.

In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of world. Asia Pacific is also a growing market due to increasing awareness for breast cancer among women’s is one of the major reasons for the growth in Asia Pacific market. North America is the leader in global breast biopsy. The reason for this dominance by North America is the availability of highly advanced and equipped instruments, growing awareness for breast cancer, and supportive governmental initiatives. Europe is one of the leading regions in global breast biopsy market. High female population is one of the major reasons for the growth of Europe market. Rest of the world is showing lesser growth, but awareness programs regarding breast cancer is accelerating the market.

Some of the major market players are Angiotech, Cardinal Health Inc., Carefusion Corp., Galini SRL, Ethicon Endo Surgery (Johnson and Johnson), Cook Medical Incorporated, Argon Medical Devices Becto, Dickinson and Company, UK Biopsy, Hologic, Inc., DTR Medical, etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

【レポートの目次】

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING DEMAND FOR MINIMAL INVASIVE SURGERY
3.1.2. INCREASING INCIDENCE OF BREAST CANCER
3.1.3. INCREASING NUMBER OF BREAST CANCER SCREENING PROGRAMS
3.2. MARKET RESTRAINTS
3.2.1. INFECTION RISKS RELATED TO BREAST BIOPSY PROCEDURE
3.2.2. REGULATORY ISSUES
3.3. MARKET OPPORTUNITIES
3.3.1. GROWTH OPPORTUNITY IN EMERGING COUNTRIES
3.3.2. TECHNOLOGICAL INNOVATION LEADS TO LESS INVASIVE AND ACCURATE SURGERY
3.4. MARKET CHALLENGES
3.4.1. HIGH COST OF BIOPSY
3.4.2. SUSCEPTIBILITY TO RADIATION EXPOSURE
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION
4.1. BY TYPE
4.1.1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
4.1.1.1. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
4.1.1.2. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
4.1.1.3. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
4.1.2. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
4.1.2.1. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
4.1.2.2. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
4.2. BY GUIDANCE
4.2.1. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
4.2.2. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
4.2.3. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
4.2.4. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
4.3. BY PRODUCTS
4.3.1. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
4.3.2. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
4.3.3. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
4.3.4. GLOBAL OTHER MARKET 2014-2022($ MILLION)

5. GEOGRAPHICAL ANALYSIS
5.1. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.1.1. UNITED STATES (U.S.) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.1.2. CANADA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.1. UNITED KINGDOM (UK) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.2. FRANCE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.3. GERMANY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.4. SPAIN GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.5. ITALY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.2.6. ROEGLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.3. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.3.1. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.2. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.3. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.4. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.3.5. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4. REST OF THE WORLDGLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
5.4.1. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4.2. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
5.4.3. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILING: – (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)
1. ANGIOTECH
2. CARDINAL HEALTH INC
3. CAREFUSION CORPORATION
4. C. R. BARD, INC
5. DEVICOR MEDICAL PRODUCTS INC.
6. DTR MEDICAL
7. HOLOGIC, INC
8. INRAD, INC
9. UK BIOPSY
10. BECTON, DICKINSON AND COMPANY
11. DEVICOR MEDICAL PRODUCTS INC.
12. ARGON MEDICAL DEVICES
13. COOK MEDICAL INCORPORATED
14. ETHICON ENDO SURGERY (JOHNSON AND JOHNSON)
15. GALINI SRL

LIST OF TABLES
1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
2. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
3. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
4. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
5. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
6. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
7. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
8. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
9. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
10. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
11. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
12. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
13. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
14. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
15. GLOBAL OTHER MARKET 2014-2022($ MILLION)
16. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
17. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
18. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
19. REST OF THE WORLD GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES
1. GLOBAL NEEDLE BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
2. GLOBAL CORE NEEDLE BIOPSY MARKET 2014-2022 ($ MILLION)
3. GLOBAL FINE NEEDLE ASPIRATION BIOPSY MARKET 2014-2022 ($ MILLION)
4. GLOBAL VACUUM ASSISTED BIOPSY MARKET 2014-2022 ($ MILLION)
5. GLOBAL OPEN SURGICAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
6. GLOBAL EXCISIONAL MARKET 2014-2022 ($ MILLION)
7. GLOBAL INCISIONAL MARKET 2014-2022 ($ MILLION)
8. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BREAST BIOPSY MARKET 2014-2022($ MILLION)
9. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
10. GLOBAL MRI GUIDED BREAST BIOPSY MARKET 2014-2022($ MILLION)
11. GLOBAL OTHER GUIDANCE TECHNIQUE MARKET 2014-2022($ MILLION)
12. GLOBAL BIOPSY NEEDLES MARKET 2014-2022($ MILLION)
13. GLOBAL GUIDANCE SYSTEMS MARKET 2014-2022($ MILLION)
14. GLOBAL LOCALIZATION WIRES MARKET 2014-2022($ MILLION)
15. GLOBAL OTHER MARKET 2014-2022($ MILLION)
16. NORTH AMERICA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
17. UNITED STATES (U.S.) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
18. CANADA GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
19. EUROPE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
20. UNITED KINGDOM (UK) GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
21. FRANCE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
22. GERMANY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
23. SPAIN GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
24. ITALY GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
25. ROE GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
26. ASIA PACIFIC GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
27. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
28. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
29. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
30. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
31. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
32. REST OF THE WORLD GLOBAL BREAST BIOPSY MARKET 2014-2022 ($ MILLION)
33. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
34. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)
35. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($ MILLION)



【レポートのキーワード】

乳房生検、乳房針生検、コア針生検、真空補助下生検

★調査レポート[乳房生検の世界市場:インサイト、市場機会、市場シェア、市場予測]販売に関する免責事項
★調査レポート[乳房生検の世界市場:インサイト、市場機会、市場シェア、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆